w372
Small moleculeexperimentalImaging agent
Clinical trial activity
1 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Aug 1, 2009 (NCT00954369)
Timeline
2000s
- Jan 1, 2009
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Amyloid beta A4 proteinRadiopharmaceutical
APP radiopharmaceutical
Chemistry & pharmacology
- Imaging
- 18-fluorine
Oral
No
Parenteral
No
Topical
No
Also known as
- w372
- w372
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00954369 | Early Phase 1 (Phase 1) | Aug 1, 2009 | Siemens, University of California, Irvine |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Siemens | For profit | 1 | 1 | 1 | 2009 |
| University of California, Irvine | Academic/Hospital | 1 | 0 | 1 | 2009 |
2 organizations
Page 1 / 1